Core Viewpoint - The Guangzhou Market Supervision Administration has launched a "Clearing Source" action to regulate drug business practices and enhance drug quality supervision across the city [1] Group 1: Action Focus - The action targets issues such as the rental and lending of licenses, production and sale of counterfeit drugs, illegal drug purchases, and the sale of prescription drugs without prescriptions [1] - A leadership team has been established to oversee the "Clearing Source" action, with the Drug and Chemical Department leading the development of the action plan [1] Group 2: Responsibilities and Compliance - The action aims to reinforce the primary responsibility of drug operating enterprises and users, urging them to conduct self-inspections across all drug procurement, sales, storage, and usage stages [1] - Special attention will be given to wholesale enterprises, retail chain headquarters, and retail enterprises that engage in abnormally low-priced drug procurement [1] Group 3: Risk Management and Enforcement - The initiative will strengthen the approval and entry mechanisms, optimize the exit mechanisms, and enhance the management of retail chain enterprises [1] - Comprehensive checks will be conducted on enterprises with a history of complaints, multiple referrals, and inadequate rectifications, including online and offline inspections [1] - The action will involve collaboration with public security, health, and medical insurance departments to thoroughly investigate potential illegal activities and enforce strict penalties for violations [1]
广州市监局部署开展药品经营环节“清源”行动
news flash·2025-06-06 07:13